Yi Hou

455 total citations
20 papers, 344 citations indexed

About

Yi Hou is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Yi Hou has authored 20 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 3 papers in Cell Biology. Recurrent topics in Yi Hou's work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (4 papers). Yi Hou is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (4 papers). Yi Hou collaborates with scholars based in China, Japan and Israel. Yi Hou's co-authors include Ke Liu, Jia Zheng, Hai Li, Wei Huo, Guanbo Wang, Hai Li, Yinan Luo, Fankai Meng, Pengfei Ge and Xiaofei Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and European Journal of Pharmacology.

In The Last Decade

Yi Hou

19 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Hou China 11 242 203 46 30 28 20 344
Jian Fan China 10 343 1.4× 112 0.6× 23 0.5× 62 2.1× 20 0.7× 26 475
Yun Gu China 11 284 1.2× 227 1.1× 36 0.8× 42 1.4× 43 1.5× 22 384
Mélanie Berta France 5 194 0.8× 162 0.8× 19 0.4× 42 1.4× 25 0.9× 5 347
Jianzhong Lin China 8 158 0.7× 84 0.4× 44 1.0× 60 2.0× 47 1.7× 13 294
Emre Can Tüysüz Türkiye 11 138 0.6× 97 0.5× 41 0.9× 39 1.3× 17 0.6× 19 302
Jianmin Sun China 11 209 0.9× 154 0.8× 21 0.5× 45 1.5× 32 1.1× 16 375
Miho Harada Japan 11 167 0.7× 102 0.5× 50 1.1× 87 2.9× 57 2.0× 27 368
Federico Virga Italy 8 338 1.4× 197 1.0× 21 0.5× 42 1.4× 27 1.0× 11 452

Countries citing papers authored by Yi Hou

Since Specialization
Citations

This map shows the geographic impact of Yi Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Hou more than expected).

Fields of papers citing papers by Yi Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Hou. The network helps show where Yi Hou may publish in the future.

Co-authorship network of co-authors of Yi Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Hou. A scholar is included among the top collaborators of Yi Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Hou. Yi Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Min, Wenjian, Chunling Chen, Yan Zhao, et al.. (2025). Discovery of a Novel and Potent MET Transcription Inhibitor Targeting Promoter G-Quadruplex for the Treatment of NSCLC. Journal of Medicinal Chemistry. 68(11). 10845–10859.
2.
Hou, Yi, et al.. (2022). A Review on Resistance to Biotic Stress in Leaf-Colored Plant. Advances in Bioscience and Biotechnology. 13(5). 226–241. 1 indexed citations
3.
Hou, Yi, et al.. (2022). Genome-Wide Identification, Evolution, and Expression Analysis of the TCP Gene Family in Rose (Rosa chinensis Jacq.). Horticulturae. 8(10). 961–961. 5 indexed citations
4.
Hou, Yi, Wenbin Kuang, Wenjian Min, et al.. (2021). Design, Synthesis, and Biological Evaluation of Icaritin Derivatives as Novel Putative DEPTOR Inhibitors for Multiple Myeloma Treatment. Journal of Medicinal Chemistry. 64(20). 14942–14954. 9 indexed citations
5.
Hou, Yi, Hai Li, & Wei Huo. (2021). MicroRNA-495 alleviates ulcerative interstitial cystitis via inactivating the JAK–STAT signaling pathway by inhibiting JAK3. International Urogynecology Journal. 32(5). 1253–1263. 11 indexed citations
6.
7.
Qi, Yitian, et al.. (2021). miR-30d-5p represses the proliferation, migration, and invasion of lung squamous cell carcinoma via targeting DBF4. PubMed. 39(3). 251–268. 12 indexed citations
8.
9.
Sun, Yan, et al.. (2020). Screening of characteristic biomolecules related to bladder cancer based on construction of ceRNA regulation network. World Journal of Urology. 38(11). 2835–2847. 8 indexed citations
10.
Li, Zhijun, Yangyang Zheng, Jinying Xu, et al.. (2020). MicroRNA-124 Overexpression in Schwann Cells Promotes Schwann Cell-Astrocyte Integration and Inhibits Glial Scar Formation Ability. Frontiers in Cellular Neuroscience. 14. 144–144. 9 indexed citations
11.
Liu, Yan, et al.. (2020). A potential prognostic model based on miRNA expression profile in The Cancer Genome Atlas for bladder cancer patients. SHILAP Revista de lepidopterología. 27(1). 6–6. 6 indexed citations
12.
Hou, Yi, Hai Li, & Wei Huo. (2020). THBS4 silencing regulates the cancer stem cell‐like properties in prostate cancer via blocking the PI3K/Akt pathway. The Prostate. 80(10). 753–763. 25 indexed citations
13.
Huo, Wei, Yi Hou, Yang Li, & Hai Li. (2019). Downregulated lncRNA-MIAT confers protection against erectile dysfunction by downregulating lipoprotein lipase via activation of miR-328a-5p in diabetic rats. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(6). 1226–1240. 19 indexed citations
14.
Liu, Yan, et al.. (2019). A 6‑gene risk score system constructed for predicting the clinical prognosis of pancreatic adenocarcinoma patients. Oncology Reports. 41(3). 1521–1530. 18 indexed citations
15.
Li, Fan, Hai Li, & Yi Hou. (2019). Identification and analysis of survival‑associated ceRNA triplets in prostate adenocarcinoma. Oncology Letters. 18(4). 4040–4047. 3 indexed citations
16.
Yin, Yu, Zhixin Wang, Xueying Zhou, et al.. (2018). miR-671 promotes prostate cancer cell proliferation by targeting tumor suppressor SOX6. European Journal of Pharmacology. 823. 65–71. 37 indexed citations
17.
Liu, Ke, et al.. (2017). LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141. Journal of Biomedical Science. 24(1). 46–46. 89 indexed citations
18.
Hou, Yi, Linpei Jia, Ying Zhang, Wei Ji, & Hai Li. (2017). Activation of the NGF/TrkA signaling pathway attenuates diabetic erectile dysfunction. Oncotarget. 8(62). 105692–105702. 9 indexed citations
19.
20.
Hou, Yi, et al.. (2011). Proteasome inhibitor MG-132 induces C6 glioma cell apoptosis via oxidative stress. Acta Pharmacologica Sinica. 32(5). 619–625. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jian Fan Breakdown of academic impact, for papers by Yun Gu Breakdown of academic impact, for papers by Mélanie Berta Breakdown of academic impact, for papers by Jianzhong Lin Breakdown of academic impact, for papers by Emre Can Tüysüz Breakdown of academic impact, for papers by Jianmin Sun Breakdown of academic impact, for papers by Miho Harada Breakdown of academic impact, for papers by Federico Virga
Rankless by CCL
2026